Maraviroc: in vitro assessment of drug–drug interaction potential

AIMS: To characterize the cytochrome P450 enzyme(s) responsible for the N-dealkylation of maraviroc in vitro, and predict the extent of clinical drug–drug interactions (DDIs). METHODS: Human liver and recombinant CYP microsomes were used to identify the CYP enzyme responsible for maraviroc N-dealkyl...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hyland, Ruth, Dickins, Maurice, Collins, Claire, Jones, Hannah, Jones, Barry
Format: Artigo
Langue:Inglês
Publié: Blackwell Science Inc 2008
Sujets:
Drug Interactions
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2561101/
https://ncbi.nlm.nih.gov/pubmed/18647303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2008.03198.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires